Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo

Suzanne M. McGoldrick, Marie E. Bleakley, Abraham Guerrero, Cameron J. Turtle, Tori N. Yamamoto, Shalini E. Pereira, Colleen S. Delaney, Stanley R. Riddell

Blood (2013) 121 (14): 2796–2803.

https://doi.org/10.1182/blood-2012-09-453720

Published: 2013

Includes: Supplemental data

Journal Articles

Generation of CD19-chimeric antigen receptor modified CD8 + T cells derived from virus-specific central memory T cells

Seitaro Terakura, Tori N. Yamamoto, Rebecca A. Gardner, Cameron J. Turtle, Michael C. Jensen, Stanley R. Riddell

Blood (2012) 119 (1): 72–82.

https://doi.org/10.1182/blood-2011-07-366419

Published: 2012

Includes: Supplemental data

Journal Articles

Generation and Signaling Function of CD19 Chimeric Antigen Receptor Modified CD8 + T Cells Derived From Virus-Specific Central Memory Cells for Adoptive Therapy After Allogeneic Hematopoietic Stem Cell Transplant

Seitaro Terakura, MD, PhD, Tori N. Yamamoto, Rebecca A. Gardner, MD, Cameron J. Turtle, MBBS, PhD, Michael C. Jensen, MD, Stanley R. Riddell, MD

Blood (2011) 118 (21): 2978.

https://doi.org/10.1182/blood.V118.21.2978.2978

Published: 2011

Journal Articles

Cytomegalovirus-Specific T Cells Are Elicited Early After Umbilical Cord Blood Transplant but Fail to Expand In Vivo and Control Virus Replication

Suzanne M. McGoldrick, MD, Abraham Guerrero, PhD, Tori N. Yamamoto, Colleen Delaney, MD, Stanley R. Riddell, MD

Blood (2011) 118 (21): 1974.

https://doi.org/10.1182/blood.V118.21.1974.1974

Published: 2011

Journal Articles

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Michael Hudecek, Thomas M. Schmitt, Sivasubramanian Baskar, Maria Teresa Lupo-Stanghellini, Tetsuya Nishida, Tori N. Yamamoto, Marie Bleakley, Cameron J. Turtle, Wen-Chung Chang, Harvey A. Greisman, Brent Wood, David G. Maloney, Michael C. Jensen, Christoph Rader, Stanley R. Riddell

Blood (2010) 116 (22): 4532–4541.

https://doi.org/10.1182/blood-2010-05-283309

Published: 2010

Includes: Supplemental data

NARROW

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo

Generation of CD19-chimeric antigen receptor modified CD8 + T cells derived from virus-specific central memory T cells

Generation and Signaling Function of CD19 Chimeric Antigen Receptor Modified CD8 + T Cells Derived From Virus-Specific Central Memory Cells for Adoptive Therapy After Allogeneic Hematopoietic Stem Cell Transplant

Cytomegalovirus-Specific T Cells Are Elicited Early After Umbilical Cord Blood Transplant but Fail to Expand In Vivo and Control Virus Replication

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Email alerts

ASH Publications

American Society of Hematology

Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo

Generation of CD19-chimeric antigen receptor modified CD8 + T cells derived from virus-specific central memory T cells

Generation and Signaling Function of CD19 Chimeric Antigen Receptor Modified CD8 + T Cells Derived From Virus-Specific Central Memory Cells for Adoptive Therapy After Allogeneic Hematopoietic Stem Cell Transplant

Cytomegalovirus-Specific T Cells Are Elicited Early After Umbilical Cord Blood Transplant but Fail to Expand In Vivo and Control Virus Replication

The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only